Your browser doesn't support javascript.
Diabetes mellitus as a risk factor for SARS-CoV-2 test positivity in Mexico: A propensity score matched study.
Seiglie, Jacqueline A; Serván-Mori, Edson; Manne-Goehler, Jennifer; Meigs, James B; Miranda, J Jaime; Sosa-Rubí, Sandra G; Silverman-Retana, Omar; Wexler, Deborah J; Wirtz, Veronika J.
  • Seiglie JA; Diabetes Unit, Massachusetts General Hospital, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA.
  • Serván-Mori E; Center for Health Systems Research, National Institute of Public Health, Cuernavaca, Mexico. Electronic address: eservan@insp.mx.
  • Manne-Goehler J; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Meigs JB; Department of General Internal Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Miranda JJ; CRONICAS Center of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru; The George Institute for Global Health, Sydney, Australia.
  • Sosa-Rubí SG; Center for Health Systems Research, National Institute of Public Health, Cuernavaca, Mexico.
  • Silverman-Retana O; Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.
  • Wexler DJ; Diabetes Unit, Massachusetts General Hospital, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA.
  • Wirtz VJ; Department of Global Health, Boston University School of Public Health, Boston, MA, USA.
Diabetes Res Clin Pract ; 178: 108953, 2021 Aug.
Article in English | MEDLINE | ID: covidwho-1322065
ABSTRACT

AIMS:

We sought to investigate whether individuals with diabetes have a higher likelihood of testing positive for SARS-CoV-2, as a proxy for infection risk, than individuals without diabetes.

METHODS:

We conducted a cross-sectional study of publicly available data among a Mexican population, totaling 2,314,022 adults ≥ 18 years who underwent SARS-CoV-2 testing between March 1 and December 20, 2020. We used 11 nearest neighborhood propensity score matching by diabetes status to account for confounding among those with and without diabetes.

RESULTS:

In the overall study population, 1,057,779 (45.7%) individuals tested positive for SARS-CoV-2 and 270,486 (11.7%) self-reported diabetes. After propensity score matching, patient characteristics were well-balanced, with 150,487 patients in the diabetes group (mean [SD] age 55.9 [12.7] years; 51.3% women) and 150,487 patients in the no diabetes group (55.5 [13.3] years; 50.3% women). The strictest matching algorithm (11 nearest neighbor) showed that compared to individuals without diabetes, having diabetes was associated with 9.0% higher odds of having a positive SARS-CoV-2 test (OR 1.09 [95% CI 1.08-1.10]).

CONCLUSIONS:

Presence of diabetes was associated with higher odds of testing positive for SARS-CoV-2, which could have important implications for risk mitigation efforts for people with diabetes at risk of SARS-CoV-2 infection.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetes Mellitus / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study / Randomized controlled trials Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Mexico Language: English Journal: Diabetes Res Clin Pract Journal subject: Endocrinology Year: 2021 Document Type: Article Affiliation country: J.diabres.2021.108953

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetes Mellitus / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study / Randomized controlled trials Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Mexico Language: English Journal: Diabetes Res Clin Pract Journal subject: Endocrinology Year: 2021 Document Type: Article Affiliation country: J.diabres.2021.108953